AThe quantity and quality of sleep can affect testosterone levels. Patients with obstructive sleep apnoea (OSA) have less REM sleep, reduced deep sleep time, increased nighttime awakenings, and reduced sleep efficiency, which can lead to lowered testosterone.
OSA is considered to be a relative contraindication because TRT can worsen sleep apnea. This means it’s important to investigate ventilatory capacity in people who may have symptoms of OSA and continue to monitor if they benefits are perceived to outweigh the risks. Few controlled studies have been released on the long-term effects of TRT in patients with OSA due to methodological limitations.
OSA can increase the risk of rising haematocrit which has been associated with clotting events. There are treatments available that can help those with OSA to maintain good oxygenation during sleep with devices that enable continuous positive airway pressure (CPAP) and help facilitate restorative sleep.
Intus offer home assessments for people who have concerns about symptoms of OSA and offer diagnosis and treatment. If you would like to benefit from a referral for their diagnostic services please use the following link and discount code here.
